iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2026 Earnings Call Transcript
Operator: Hello everyone. Thank you for joining us and welcome to iRhythm Technologies, Inc. Q1 2026 earnings conference call.
Irhythm Holdings Inc. (IRTC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,608,014 | $189,777,812 | +95% | 0.08% |
| 2. | Holocene Advisors Brandon Haley | 1,248,658 | $147,366,617 | +83% | 0.36% |
| 3. | Braidwell LP Alex Karnal | 610,192 | $72,014,860 | +181% | 2.4% |
| 4. | Point72 Asset Management Steve Cohen | 599,405 | $70,741,778 | +174% | 0.09% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 582,879 | $68,791,380 | -4% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.71 | 5,312 | $56,891.52 | 25,611 | 2026-05-11 | Filing | |
| $75.16 | 6,664 | $500,866.24 | 18,941 | 2024-11-04 | Filing | |
| $74.98 | 280 | $20,994.40 | 40,145 | 2024-05-31 | Filing | |
| $102.27 | 9,755 | $997,643.85 | 128,510 | 2023-06-06 | Filing | |
| $17.00 | 100,000 | $1,700,000.00 | 2,124,448 | 2016-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $108.19 | 1,716 | $185,652.50 | 40,287 | 2026-06-02 | Filing | |
| $108.19 | 729 | $78,870.00 | 16,155 | 2026-06-02 | Filing | |
| $120.53 | 290 | $34,953.70 | 20,299 | 2026-05-11 | Filing | |
| $119.16 | 1,147 | $136,671.59 | 20,589 | 2026-05-11 | Filing | |
| $118.02 | 2,293 | $270,611.38 | 21,736 | 2026-05-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,741,505 | $323,552,391 | 0.01% | |
| 2. | 1,796,372 | $212,007,823 | 0.01% | |
| 3. | 1,668,500 | $196,916,370 | 1.96% | |
| 4. | 1,450,907 | $171,236,007 | 0.27% | |
| 5. | 1,445,710 | $170,622,694 | 0% |
News See All
Truist Cuts PT on iRhythm Technologies (IRTC) as Part of Fiscal Q1 Results Preview in MedTech
iRhythm Technologies, Inc. (NASDAQ:IRTC) is one of the best medical device stocks to invest in right now. Truist cut the price target on iRhythm Technologies, Inc.
10 Best Medical Device Stocks to Invest In Right Now
On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on CNBC's ‘Power Lunch’ to discuss the outlook for equity markets.
10 Best Medical AI Stocks to Buy Now
Artificial intelligence has driven significant gains in the equity market over the past two years.
iRhythm Holdings, Inc. (IRTC) Reports $5.6M Net Income, 70.9% Gross Margin in Q4 2025
On February 19, iRhythm Holdings, Inc. (NASDAQ:IRTC) published its results for the fourth quarter and the entire year of 2025.
10 Fastest Growing Mid Cap Stocks to Buy Now
The Federal Reserve’s pivot from higher interest rates to rate cuts is creating a meaningful shift for mid-cap stocks, according to Amy Y. Zhang, portfolio manager of the Alger Mid Cap 40 ETF.
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2025 Earnings Call Transcript
Operator: Hello, everyone. Thank you for attending today's iRhythm Holdings, Inc. Q4 2025 Earnings Conference Call. My name is William, and I will be your moderator today.
Here’s Artisan Mid Cap Fund’s Updates on iRhythm (IRTC)
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Fund”. A copy of the letter can be downloaded here.
Here is Why Hedge Funds Are Appreciating iRhythm Holdings (IRTC)
The rating came after iRhythm Holdings (NASDAQ:IRTC) announced its preliminary results for the fourth quarter, posting revenues of around $207 million amid volumetric growth.
12 Best Medical Devices Stocks to Invest In According to Hedge Funds
It is challenging to identify segments within the markets that appear to be defensive plays, yet offer innovation potential.
Hedge Fund Resource Center